Furthermore, based on in vitro and xenograft models, STAT3 is thought to play a tumour-promoting role in non-small-cell lung cancer (NSCLC) and during acquired drug resistance13, 14, 16, 17, 18. This evidence concerns the gene STAT3 and neoplasm.